Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Hongqiong Xie"'
Publikováno v:
OncoTargets and Therapy. 13:12163-12168
Relapsed and refractory (R/R) mantle cell lymphoma (MCL) remains an incurable lymphoma with a poor prognosis. Recently, there are a few studies demonstrating the efficacy of anti-CD19 chimeric antigen receptor T (CAR-T) cell therapy in MCL, including
Autor:
Yang, Chunmei (AUTHOR), Lei, Wen (AUTHOR), Xie, Hongqiong (AUTHOR), Wu, Gongqiang (AUTHOR), Wei, Juying (AUTHOR), Liang, Aibin (AUTHOR), Qian, Wenbin (AUTHOR)
Publikováno v:
OncoTargets & Therapy. Nov2020, Vol. 13, p12163-12168. 6p.